Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2003
12/31/2003WO2002079381A3 Biosynthesis of s-adenosylmethionine in a recombinant yeast strain
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
12/31/2003WO2002038766A3 Human tumor necrosis factor receptor
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464064A Process for preparing telomeric repeat binding factor (TRF1) monoclonal antibodies and use thereof
12/31/2003CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond
12/31/2003CN1132842C Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli
12/31/2003CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4
12/31/2003CA2490517A1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives
12/31/2003CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490384A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein
12/31/2003CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670451 Netrins
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670326 Depsipeptide compound
12/30/2003US6670173 Bioreaction module for biochemical reactions
12/30/2003US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors
12/30/2003US6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670126 Poly-primed amplification of nucleic acid sequences
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2163641C Multiple sclerosis virus
12/25/2003US20030236396 Secretory signal sequences and uses thereof
12/25/2003US20030236392 Genetic engineering; polypeptide library
12/25/2003US20030236390 Materials for the production of nanometer structures and use thereof
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235884 Hybrid protein; process control; glycosylation
12/25/2003US20030235869 Biological products
12/25/2003US20030235852 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same using peptide modifying agents
12/25/2003US20030235851 Fusion proteins; combinatorial libraries
12/25/2003US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
12/25/2003US20030235831 Nucleic acids, proteins, and antibodies
12/25/2003US20030235829 Nucleic acids, proteins, and antibodies
12/25/2003US20030235826 Gene and protein specific for excitable tissues
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235582 Anti-IGF-I receptor antibody
12/25/2003US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer
12/24/2003WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/24/2003WO2003106674A2 Means and methods for regulating gene expression
12/24/2003WO2003106669A1 Purified pkb ser 473 kinase and uses thereof
12/24/2003WO2003106658A2 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
12/24/2003WO2003106621A2 Anti-igf-i receptor antibody
12/24/2003WO2003105782A2 Specificity grafting of a murine antibody onto a human framework
12/24/2003WO2003083113A3 Growth regulating proteins
12/24/2003WO2003072742A3 Novel glucose 6-oxidases
12/24/2003WO2003064630A3 Cell culture medium
12/24/2003WO2003064473A3 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
12/24/2003WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
12/24/2003WO2003038095A3 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
12/24/2003WO2003027322A3 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
12/24/2003WO2003025154A3 Methods and compositions for the construction and use of fusion libraries
12/24/2003WO2003014353A3 Genetic products of ashbya gossypii, associated with transmembrane transport
12/24/2003WO2003000113A3 Compositions and methods for the diagnosis and treatment of tumor
12/24/2003WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same
12/24/2003WO2002092764A3 Transgenic animal model of bone mass modulation
12/24/2003WO2002088375A3 Compositions and methods relating to breast specific genes and proteins
12/24/2003WO2002088170A3 Cripto blocking antibodies and uses thereof
12/24/2003WO2002074969A3 Matrix attachment regions and methods for use thereof
12/24/2003WO2002072831A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/24/2003WO2002026805A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/24/2003WO2001092542A8 Integrin-targeting vectors having enhanced transfection activity
12/24/2003WO2001058923A3 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
12/24/2003CN1462803A Technqiue for preapring small interfering expression vector of ribonucleic acid of mammal cell
12/24/2003CN1131663C Hypersensitive response induced resistance in plants
12/24/2003CA2723500A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
12/24/2003CA2722998A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
12/24/2003CA2489440A1 Anti-igf-i receptor antibody
12/24/2003CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
12/24/2003CA2488924A1 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
12/24/2003CA2487321A1 Specificity grafting of a murine antibody onto a human framework
12/23/2003US6667176 cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
12/23/2003US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells.
12/23/2003US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A)
12/23/2003CA2087342C Serine protease variants having peptide ligase activity
12/18/2003WO2003104803A2 Method for mapping and eliminating t-cell epitopes
12/18/2003WO2003104430A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/18/2003WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003059953A3 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003029427A3 Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
12/18/2003WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
12/18/2003WO2003018810A3 Modified cry3a toxins and nucleic acid sequences coding therefor
12/18/2003WO2003009817B1 Stable lyophilized pharmaceutical formulation of igg antibodies
12/18/2003WO2003004510A1 Two-stage protective groups for the synthesis of biopolymers
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002086059A3 Recombinant vaccinia viral vectors
12/18/2003WO2002066668A3 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 1125